AC
BIVV

Avestar Capital’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Avestar Capital’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-760
Closed -$30K – 993
2017
Q4 		$30K Buy
+760
New +$41.6K 0.02% 300

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Avestar Capital's BIVV Position: Q1 2018 in Review

Avestar Capital sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 760 shares — an estimated $30K sold.

Avestar Capital first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $30K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Avestar Capital reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Avestar Capital sold 760 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $30K.
  • Avestar Capital first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Avestar Capital's Bioverativ Inc. Common Stock position peaked at $30K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Avestar Capital's 13F filing for Q1 2018, filed 10 May 2018.